Skip to main content

Table 1 Primary indices’ rates of hematologic malignancies in 1990 and 2017 at the global level

From: A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017

Measure

Metric

Hodgkin lymphoma

Non-Hodgkin lymphoma

Multiple myeloma

Leukemia

1990 (95% UI)

2017 (95% UI)

Statistically Significant?

1990 (95% UI)

2017 (95% UI)

Statistically Significant?

1990 (95% UI)

2017 (95% UI)

Statistically Significant?

1990 (95% UI)

2017 (95% UI)

Statistically Significant?

Prevalence

Number

378,758 (286,249 to 414,343)

657,094 (568,931 to 780,837)

Yes

857,555 (828,438 to 895,762)

2,371,891 (2,324,951 to 2,418,127)

Yes

147,856 (132,552 to 171,190)

449,310 (414,568 to 520,850)

Yes

1,528,800 (1,272,203 to 1,797,889)

2,432,388 (2,190,332 to 2,591,602)

Yes

Rate

7.2 (5.4 to 7.8)

8.3 (7.2 to 9.9)

No

18.9 (18.4 to 19.6)

29.7 (29.1 to 30.3)

Yes

3.5 (3.2 to 4.1)

5.5 (5.1 to 6.4)

Yes

30.2 (25.9 to 34.5)

32.4 (29 to 34.6)

No

Incidence

Number

72,937 (55,801 to 79,370)

101,133 (87,968 to 118,746)

Yes

206,863 (199,638 to 216,794)

487,964 (478,850 to 496,904)

Yes

65,487 (60,070 to 76,525)

152,746 (140,564 to 172,662)

Yes

354,471 (308,198 to 399,303)

518,485 (472,240 to 548,018)

Yes

Rate

1.4 (1.1 to 1.6)

1.3 (1.1 to 1.5)

No

4.7 (4.6 to 4.9)

6.2 (6.1 to 6.3)

Yes

1.6 (1.5 to 1.9)

1.9 (1.8 to 2.2)

No

7.4 (6.6 to 8.2)

6.8 (6.1 to 7.2)

No

Death

Number

35,946 (27,329 to 39,412)

32,560 (27,644 to 38,086)

No

134,689 (129,673 to 142,079)

248,636 (243,475 to 253,064)

Yes

52,277 (48,480 to 61,265)

107,114 (98,521 to 118,911)

Yes

264,888 (234,391 to 292,591)

347,583 (317,256 to 364,877)

Yes

Rate

0.8 (0.6 to 0.8)

0.4 (0.4 to 0.5)

Yes

3.2 (3.1 to 3.3)

3.2 (3.1 to 3.2)

No

1.3 (1.3 to 1.6)

1.4 (1.3 to 1.5)

No

5.8 (5.3 to 6.3)

4.5 (4.1 to 4.7)

Yes

YLLs

Number

1,625,133 (1,205,998 to 1,807,341)

1,327,631 (1,110,146 to 1,567,680)

No

4,497,053 (4,162,545 to 4,943,867)

6828,795 (6,611,841 to 7,019,991)

Yes

1,183,624 (1,095,061 to 1,349,698)

2,234,726 (2,091,390 to 2,493,151)

Yes

11,806,875 (9,724,465 to 13,876,452)

11,712,000 (10,531,416 to 12,523,323)

No

Rate

30.9 (23.1 to 34)

17.1 (14.3 to 20.2)

Yes

92.9 (87.2 to 100.7)

86.8 (84 to 89.5)

No

28 (26 to 32.3)

27.7 (25.9 to 30.8)

No

221.9 (186.7 to 255.8)

153.4 (137.9 to 164.5)

Yes

YLDs

Number

32,336 (21,127 to 44,675)

50,534 (35,126 to 69,346)

No

76,792 (55,686 to 100,940)

193,118 (140,222 to 254,172)

Yes

32,531 (22,814 to 42,284)

90,764 (64,211 to 118,424)

Yes

164,720 (116,396 to 222,554)

263,348 (191,210 to 342,035)

No

Rate

0.6 (0.4 to 0.9)

0.6 (0.4 to 0.9)

No

1.7 (1.3 to 2.3)

2.4 (1.8 to 3.2)

No

0.8 (0.5 to 1)

1.1 (0.8 to 1.5)

No

3.5 (2.5 to 4.6)

3.4 (2.5 to 4.5)

No

DALYs

Number

1,657,469 (1,228,330 to 1,843,223)

1,378,166 (1,155,059 to 1,624,392)

No

4,573,845 (4,236,062 to 5,018,937)

7,021,913 (6,794,727 to 7,232,477)

Yes

1,216,155 (1,127,669 to 1,388,918)

2,325,490 (2,176,068 to 2,606,756)

Yes

11,971,595 (9,868,922 to 14,047,583)

11,975,348 (10,749,148 to 12,793,575)

No

Rate

31.5 (23.6 to 34.7)

17.8 (14.9 to 20.9)

Yes

94.6 (88.9 to 102.5)

89.3 (86.1 to 92.2)

No

28.8 (26.7 to 33.3)

28.8 (26.9 to 32.2)

No

225.4 (190.2 to 259.3)

156.8 (140.8 to 168.1)

Yes

  1. Data are derived from GBD 2017. Both age-standardized and crude rates (with 95% uncertainty intervals) of primary indices are represented in the table. DALYs disability-adjusted life-years, GBD Global Burden of Disease, YLDs years lived with disability, YLLs years of life lost